Trial intelligence / Profile preview

ADRCs for Partial Thickness Rotator Cuff Tears

NCT02918136Completed

Sponsor
InGeneron
Start
Dec 2016
Primary completion
Jul 2018
Modality
Stem Cell Therapies
Countries
1
01

Overview

Randomised, open-label trial of autologous adipose-derived stem/stromal cells in rotator cuff tear (2 arms), sponsored by InGeneron. Primary endpoints: Adverse Events at 12 months, Rand Short Form-36 Questionnaire at 12 months and 1 more. Started Dec 2016; status: completed.

02

Drugs

autologous adipose-derived stem/stromal cells
03

Conditions

rotator cuff tear

Beyond the preview

Go deeper on NCT02918136.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02918136.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call